NCT01448993View on ClinicalTrials.gov

Effect of Azithromycin on Oesophageal Hypomotility

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Esophageal Motility Disorders
Interventions
DRUG

Azithromycin

Taking 250mg azithromycin 3 times per week in alternate days.

DRUG

Placebo

Trial Locations (1)

E1 1BB

Royal London Hospital, London

All Listed Sponsors
lead

JAFAR JAFARI

OTHER

NCT01448993 - Effect of Azithromycin on Oesophageal Hypomotility | Biotech Hunter | Biotech Hunter